is a topic covered in the Johns Hopkins ABX Guide
To view the entire topic, please sign in or purchase a subscription.
Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:
-- The first section of this topic is shown below --
- Due to potential for severe hepatitis, adrenal insufficiency, and drug-drug interactions, systemic ketoconazole should not be used as first line for any fungal infections.
- Treatment of blastomycosis, coccidioidomycosis, histoplasmosis, chromomycosis, and paracoccidioidomycosis.
-- To view the remaining sections of this topic, please sign in or purchase a subscription --
Last updated: August 26, 2013
TY - ELEC
T1 - Ketoconazole
ID - 540300
A1 - Bartlett,John,M.D.
AU - Pham,Paul,Pharm.D.
Y1 - 2013/08/26/
BT - Johns Hopkins ABX Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540300/all/Ketoconazole
PB - The Johns Hopkins University
DB - Pediatrics Central
DP - Unbound Medicine